Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
EVOK Evoke Pharma, Inc. daily Stock Chart
EVOK [NASD]
Evoke Pharma, Inc.
Healthcare | Drugs - Generic | USA
statements
Index- P/E- EPS (ttm)-0.33 Insider Own1.10% Shs Outstand25.32M Perf Week23.91%
Market Cap28.11M Forward P/E- EPS next Y-0.14 Insider Trans0.00% Shs Float23.42M Perf Month-15.33%
Income-7.10M PEG- EPS next Q-0.05 Inst Own14.50% Short Float1.01% Perf Quarter-33.53%
Sales- P/S- EPS this Y29.90% Inst Trans-0.81% Short Ratio1.22 Perf Half Y27.95%
Book/sh0.18 P/B6.17 EPS next Y26.30% ROA-110.80% Target Price8.00 Perf Year-18.98%
Cash/sh0.23 P/C4.93 EPS next 5Y40.00% ROE-150.20% 52W Range0.50 - 2.00 Perf YTD-31.48%
Dividend- P/FCF- EPS past 5Y32.00% ROI- 52W High-44.50% Beta1.90
Dividend %- Quick Ratio3.10 Sales past 5Y- Gross Margin- 52W Low121.96% ATR0.14
Employees5 Current Ratio3.10 Sales Q/Q- Oper. Margin- RSI (14)48.56 Volatility15.40% 14.25%
OptionableNo Debt/Eq0.00 EPS Q/Q42.30% Profit Margin- Rel Volume0.97 Prev Close1.15
ShortableYes LT Debt/Eq0.00 EarningsMar 18 AMC Payout- Avg Volume193.85K Price1.11
Recom3.00 SMA201.93% SMA50-15.55% SMA200-0.38% Volume188,633 Change-3.48%
Mar-05-19Downgrade H.C. Wainwright Buy → Neutral
Mar-08-18Reiterated B. Riley FBR, Inc. Buy $10 → $5
Oct-19-17Resumed FBR & Co. Buy $10
Mar-16-17Reiterated Rodman & Renshaw Buy $6 → $9
Jan-30-17Upgrade Laidlaw Neutral → Buy $8
Jan-05-17Upgrade Rodman & Renshaw Neutral → Buy $2.50 → $6
Dec-23-16Reiterated Rodman & Renshaw Neutral $2 → $2.50
Jul-19-16Reiterated FBR Capital Outperform $17 → $9
Jul-19-16Downgrade Noble Financial Buy → Hold
Jul-18-16Downgrade Rodman & Renshaw Buy → Neutral $2
Mar-16-16Initiated Northland Capital Outperform
Mar-14-16Reiterated Ascendiant Capital Markets Buy $11 → $12
Feb-17-16Resumed FBR Capital Outperform $17
Dec-03-14Reiterated MLV & Co Buy $12.50 → $14
Nov-07-14Initiated MLV & Co Buy $12.50
Apr-22-14Initiated Laidlaw Buy $19
Nov-19-13Initiated Aegis Capital Buy $60
Mar-12-20 08:30AM  Evoke Pharma Reports Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire -18.02%
Jan-27-20 08:30AM  Evoke Pharma Receives Notice of Allowance from USPTO for Gimoti GlobeNewswire
Jan-23-20 08:30AM  Evoke Pharma Enters Commercialization Agreement with EVERSANA Life Sciences for Gimoti GlobeNewswire +5.48%
Jan-22-20 10:00AM  Evoke Pharma's NDA Resubmission for Gimoti Gets FDA Acceptance Zacks
Jan-21-20 08:30AM  FDA Accepts Evoke Pharmas NDA Resubmission for Gimoti GlobeNewswire
Dec-20-19 08:30AM  Evoke Resubmits Gimoti New Drug Application to FDA GlobeNewswire
Dec-02-19 08:30AM  Evoke Pharma Regains Compliance with Nasdaq Minimum Bid Requirement GlobeNewswire
Nov-18-19 08:52AM  What Kind Of Shareholder Appears On The Evoke Pharma, Inc.'s (NASDAQ:EVOK) Shareholder Register? Simply Wall St. +34.55%
Nov-13-19 08:30AM  Evoke Pharma Granted 180-Day Extension by Nasdaq Regarding Minimum Bid Price GlobeNewswire
Nov-07-19 08:30AM  Evoke Pharma Reports Third Quarter 2019 Financial Results GlobeNewswire
Sep-20-19 05:14PM  Foamix Initiates Phase II Study on Acne Combination Foam Zacks
Sep-19-19 12:02PM  When Will Evoke Pharma, Inc. (NASDAQ:EVOK) Come Back To Market? Simply Wall St.
10:29AM  Zynerba Releases Data on Epilepsy Candidate, Stock Down Zacks
Sep-17-19 08:30AM  Evoke Pharma Completes Manufacturing of Commercial Scale Registration Batches of Gimoti GlobeNewswire
Aug-08-19 05:30AM  Evoke Pharma to Resubmit Gimoti NDA Based on FDA Meeting Minutes and Announces Second Quarter 2019 Financial Results GlobeNewswire -8.03%
Jul-25-19 12:58PM  Biotech Stock On The Radar: Evoke Pharma Sets Date With FDA Benzinga -7.89%
Jul-11-19 11:31AM  Is Evoke Pharma, Inc. (NASDAQ:EVOK) A Volatile Stock? Simply Wall St.
Jun-27-19 08:30AM  Evoke Pharma Requests Type A FDA Meeting to Plan for Resubmission of Gimoti NDA GlobeNewswire +7.98%
May-08-19 04:05PM  Evoke Pharma Reports First Quarter 2019 Financial Results GlobeNewswire
11:39AM  Evoke Pharma (EVOK) to Post Q1 Earnings: What's in Store? Zacks
Apr-29-19 09:13AM  Investors Who Bought Evoke Pharma (NASDAQ:EVOK) Shares Five Years Ago Are Now Down 92% Simply Wall St.
Apr-15-19 12:08PM  Dr. Reddy's (RDY) Inks Deal to Acquire Portfolio of 42 ANDAs Zacks
Apr-03-19 08:19AM  The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis Earnings Benzinga
Apr-02-19 06:00AM  Evoke Pharma Receives Complete Response Letter and Recommendations to Address Deficiencies from FDA for Gimoti NDA GlobeNewswire -47.06%
Mar-29-19 12:45PM  Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates Benzinga +9.49%
Mar-14-19 08:30AM  Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA GlobeNewswire +17.50%
Mar-06-19 08:30AM  Evoke Pharma Reports Fourth Quarter and Full Year 2018 Financial Results and FDA Communication GlobeNewswire
Mar-04-19 08:30AM  Evoke Pharma Receives Preliminary FDA Communication on Gimoti NDA GlobeNewswire -57.24%
Feb-27-19 08:30AM  Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results GlobeNewswire
Jan-07-19 08:30AM  Evoke Pharma Signs Commercial and Financial Agreement for its Lead Product Gimoti in the U.S. with Novos Growth Partners GlobeNewswire
Jan-04-19 07:56AM  Loss-Making Evoke Pharma, Inc. (NASDAQ:EVOK) Expected To Breakeven Simply Wall St.
Nov-13-18 04:05PM  Evoke Pharma Reports Third Quarter 2018 Results GlobeNewswire
Oct-16-18 10:32AM  Shareholders Should Check The Ownership Structure Of Evoke Pharma Inc (NASDAQ:EVOK) Simply Wall St.
Oct-08-18 06:28PM  Generic-Drugs Stock Outlook: No Respite from Pricing Issues Zacks
Sep-28-18 09:59AM  Forget Mylan, Invest in These 3 Generic/Drug Stocks Instead Zacks
Aug-17-18 09:12AM  Evoke Pharma (EVOK) Announces FDA Acceptance of Gimoti NDA Zacks
Aug-16-18 08:30AM  Evoke Pharmas Gimoti NDA Accepted for FDA Review GlobeNewswire
Aug-09-18 04:05PM  Evoke Pharma Reports Second Quarter 2018 Results and Recent Highlights GlobeNewswire
Jun-06-18 01:38PM  At $2.8701, Is Evoke Pharma Inc (NASDAQ:EVOK) A Buy? Simply Wall St.
Jun-04-18 07:30AM  Evoke Announces FDA Submission of New Drug Application for Gimoti GlobeNewswire
May-14-18 10:27AM  Evoke Pharma Inc (NASDAQ:EVOK) Is Expected To Breakeven Simply Wall St.
06:30AM  Evoke Pharma Reports First Quarter 2018 Results and Highlights GlobeNewswire
May-10-18 07:30AM  Evoke Granted Gender Specific Patent for Gimoti in Mexico GlobeNewswire
Apr-30-18 07:30AM  Evoke Granted First Gender Specific Patent for Gimoti GlobeNewswire
Mar-26-18 07:30AM  Evoke Announces Agreement with Mallinckrodt to Amend Milestone Payments GlobeNewswire
Mar-07-18 04:05PM  Evoke Pharma Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights GlobeNewswire
12:00PM  Evoke Pharma, Inc. to Host Earnings Call ACCESSWIRE
Mar-06-18 07:30AM  Evoke Pharma to Present at the Upcoming Roth and Oppenheimer Investor Conferences GlobeNewswire
Mar-05-18 07:30AM  FDA Approves PDUFA Fee Waiver for Gimoti New Drug Application GlobeNewswire
Feb-21-18 08:30AM  Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2017 Financial Results GlobeNewswire
Feb-15-18 07:30AM  Evoke Announces Discovery of Sex-Based Pharmacokinetic Differences for Gimoti GlobeNewswire
Dec-12-17 07:40AM  Wired News Akaris Phase-II COBALT Trial of Coversin in Patients with PNH Met the Primary Endpoint ACCESSWIRE
Dec-11-17 07:30AM  Wired News SteadyMed Reported FDA Agreed Pathway to Trevyent NDA Resubmission ACCESSWIRE
Nov-14-17 04:05PM  Evoke Pharma Reports Third Quarter 2017 Results and Highlights GlobeNewswire
12:00PM  Evoke Pharma, Inc. to Host Earnings Call ACCESSWIRE
06:49AM  A Look At Evoke Pharma Inc (EVOK) And The Healthcare Sector Simply Wall St.
Nov-09-17 08:30AM  Evoke Pharma Signs Commercial Agreement with Thermo Fisher Scientific GlobeNewswire
Nov-07-17 08:30AM  Evoke Pharma Schedules Conference Call and Webcast for Third Quarter 2017 Financial Results GlobeNewswire
06:33AM  Is It The Right Time To Buy Evoke Pharma Inc (EVOK)? Simply Wall St.
Oct-27-17 08:30AM  Evoke Pharma Announces Conference Call to Review the Successful Results of Comparative Exposure Pharmacokinetic Study for Gimoti GlobeNewswire
Oct-23-17 07:30AM  Evoke Pharma Announces Positive Topline Results from Comparative Exposure Pharmacokinetic Study for Gimoti GlobeNewswire
Oct-17-17 09:53AM  New Strong Sell Stocks for October 17th Zacks
Oct-04-17 08:30AM  Evoke Pharma to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference GlobeNewswire
Sep-12-17 08:30AM  Evoke Pharma Completes Dosing for Gimoti Comparative Exposure Pharmacokinetic Study GlobeNewswire
Sep-05-17 08:30AM  Evoke Pharma to Present at the 19th Annual Rodman & Renshaw Global Investment Conference GlobeNewswire
Aug-14-17 04:05PM  Evoke Pharma Reports Second Quarter 2017 Results and Highlights GlobeNewswire
12:10PM  Investor Network: Evoke Pharma, Inc. to Host Earnings Call ACCESSWIRE
08:30AM  Evoke Pharma Initiates Comparative Exposure Pharmacokinetic Study for Gimoti GlobeNewswire
Aug-07-17 08:30AM  Evoke Pharma Schedules Conference Call and Webcast for Second Quarter 2017 Financial Results GlobeNewswire
May-31-17 08:30AM  Evoke Pharma Enters Agreement with Rho to Submit NDA for Gimoti GlobeNewswire
May-15-17 04:05PM  Evoke Pharma Reports First Quarter 2017 Results GlobeNewswire
03:00PM  Investor Network: Evoke Pharma, Inc. to Host Earnings Call Accesswire
May-10-17 08:30AM  Evoke Pharma Presents Gimoti Efficacy and Safety Data from Phase 3 Trial as Late Breaker at Digestive Disease Week 2017 GlobeNewswire
May-01-17 08:30AM  Evoke Pharma Schedules Conference Call and Webcast for First Quarter 2017 Financial Results GlobeNewswire
Apr-18-17 08:30AM  Evoke Pharma Announces Collaboration with Spaulding Clinical Research for the Gimoti Comparative Exposure Pharmacokinetic Trial GlobeNewswire
Apr-04-17 08:30AM  Positive Type A Meeting with FDA Confirms Acceptability of Evoke Pharmas Proposed Comparative Exposure PK Trial for Gimoti NDA GlobeNewswire
08:30AM  Positive Type A Meeting with FDA Confirms Acceptability of Evoke Pharmas Proposed Comparative Exposure PK Trial for Gimoti NDA
Mar-22-17 01:04PM  EVOKE PHARMA INC Financials
Mar-21-17 08:30AM  Evoke Pharmas Phase 3 Results for Gimoti Accepted as Late-Breaker for Presentation at Digestive Disease Week 2017 GlobeNewswire
Mar-15-17 04:12PM  EVOKE PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  Evoke Pharma Reports Fourth Quarter and Full Year 2016 Results GlobeNewswire
07:07AM  Q4 2016 Evoke Pharma Inc Earnings Release - After Market Close
Mar-10-17 05:19PM  EVOKE PHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Mar-07-17 08:30AM  Evoke Pharma Schedules Webcast and Conference Call for Fourth Quarter and Full-Year 2016 Financial Results GlobeNewswire
Mar-06-17 08:30AM  Evoke Pharma Announces Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
Feb-16-17 04:15PM  EVOKE PHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:30AM  Biotech Industry Poised for a Breakout in 2017? Today's Reports on Evoke Pharma and Novavax Accesswire
08:46AM  Evoke Pharma Announces Pricing of Public Offering of Common Stock GlobeNewswire
Feb-15-17 04:42PM  Evoke Pharma Announces Proposed Public Offering of Common Stock GlobeNewswire
10:55AM  Why Evoke Pharma Shares Are Exploding 24/7 Wall St.
10:55AM  Why Evoke Pharma Shares Are Exploding
08:49AM  Evoke Pharma's stock soars after FDA exempts Gimoti from HF Validation at MarketWatch
08:43AM  EVOKE PHARMA INC Files SEC form 8-K, Other Events
08:30AM  FDA Exempts Evoke from Requirement for Human Factor Validation Study GlobeNewswire
Jan-31-17 09:30AM  Biotech Acquisitions on the Rise in 2017: Latest Reports on Calithera Biosciences and Evoke Pharma Accesswire
Jan-30-17 12:54PM  Evoke Pharma upgraded by Laidlaw
Jan-09-17 08:41AM  EVOKE PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financi
08:30AM  Evoke Pharma to Attend 2017 JPMorgan Healthcare Conference GlobeNewswire
Jan-05-17 09:38AM  Evoke Diabetic Gastroparesis Drug Gimoti Positive in Phase III Zacks
Jan-04-17 12:15PM  Wednesdays Top 5 Biopharma Movers
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray, which is completed Phase III clinical trials for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. The company was founded in 2007 and is headquartered in Solana Beach, California.
open in yahoo | open in reuters | open in google